Literature DB >> 32537

Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.

P M Whitaker, P Seeman.   

Abstract

Since it was known that d-lysergic acid diethylamide (LSD) affected catecholaminergic as well as serotoninergic neurons, the objective in this study was to enhance the selectivity of [3H]LSD binding to serotonin receptors in vitro by using crude homogenates of calf caudate. In the presence of a combination of 50 nM each of phentolamine (added to preclude the binding of [3H]LSD to alpha-adrenoceptors), apomorphine, and spiperone (added to preclude the binding of [3H]LSD to dopamine receptors), it was found by Scatchard analysis that the total number of [3H]LSD sites went down to 300 fmol/mg, compared to 1100 fmol/mg in the absence of the catecholamine-blocking drugs. The IC50 values (concentrations to inhibit binding by 50%) for various drugs were tested on the binding of [3H]LSD in the presence of 50 nM each of apomorphine (A), phentolamine (P) and spiperone (S). With this combination, the IC50 for serotonin was 35 nM (compared to 1000 nM without it), indicating that [3H]LSD had become considerably more selectively displaceable by serotonin under these conditions whereas the effects of norepinephrine and dopamine on [3H]LSD binding were eliminated. Various ergots had approximately equal IC50 values against [3H]serotonin and [3H]LSD but tryptamines were much more selective against [3H]serotonin; the data may indicate the existence of the two types of serotonin receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 32537      PMCID: PMC393059          DOI: 10.1073/pnas.75.12.5783

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  LSD-25 and the status and level of brain serotonin.

Authors:  D X FREEDMAN; N J GIARMAN
Journal:  Ann N Y Acad Sci       Date:  1962-01-13       Impact factor: 5.691

2.  Serotonin-LSD interactions.

Authors:  J H GADDUM
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

3.  A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

Authors:  D W Woolley; E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1954-04       Impact factor: 11.205

4.  Neurotransmitter action on the membrane of Mytilus smooth muscle--III. Serotonin.

Authors:  Y Muneoka; G A Cottrell; B M Twarog
Journal:  Gen Pharmacol       Date:  1977

5.  Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain.

Authors:  D R Burt; I Creese; S H Snyder
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

6.  Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.

Authors:  M Titeler; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

7.  Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

Authors:  J P Green; C L Johnson; H Weinstein; S Maayani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Evidence for more than one type of 5-hydroxytryptamine receptor in the human colon.

Authors:  D E Burleigh
Journal:  J Pharm Pharmacol       Date:  1977-09       Impact factor: 3.765

9.  Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.

Authors:  M E Trulson; A D Stark; B L Jacobs
Journal:  Eur J Pharmacol       Date:  1977-07-15       Impact factor: 4.432

10.  Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.

Authors:  H Y Meltzer; R G Fessler; M Simonovic; J Doherty; V S Fang
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

View more
  5 in total

1.  In vitro and in vivo disposition of 3H-methiothepin in brain tissues. Relationship to the effects of acute treatment with methiothepin on central serotoninergic receptors.

Authors:  D L Nelson; A Herbet; L Pichat; J Glowinski; M Hamon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

2.  Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.

Authors:  R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Effect of antidepressant drugs on serotonergic and adrenergic receptors.

Authors:  S W Tang; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-04       Impact factor: 3.000

4.  A pharmacological analysis of the hyperactivity syndrome induced by beta-phenylethylamine in the mouse.

Authors:  C T Dourish
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

5.  Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.

Authors:  S J List; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.